Refine by
Applications
- 3D bioprinting technology for breast disease
- 3D bioprinting technology for lung disease
- 3D bioprinting technology for brain disease
- 3D bioprinting technology for liver disease
- 3D bioprinting technology for skin disease
- 3D bioprinting technology for pancreas disease
- 3D bioprinting technology for prostate disease
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Software Solutions for Deep Mutational Scanning & Selection
- Software Solutions for COVID-19
T Cell Subtypes From Naive T Cells Equipment & Supplies
529 equipment items found
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We are developing cell culture media for T-cell subtype control to improve clinical potency in the individual patient and reduction of variability in outcomes between patients. CAR T-cell therapy involves the treatment of cancer by modifying a patient’s T-cells in the lab so they will attack cancer cells. If clinical development of the CART T-cell produces the wrong T-cell subtype, patient ...
by:Ab Studio Inc. based inHayward, CALIFORNIA (USA)
Bispecific antibodies with computationally optimized differential binding affinities, biochemical and biophysical features, and a common light ...
Manufactured by:ALL Chemistry Inc. based inMarlton, NEW JERSEY (USA)
Concanavalin A is a plant lectin that is a T cell mitogen. It induces apoptosis in human ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Thymopentin, also known as TP-5, is a synthetic derivative of thymopoietin, a thymic hormone, and has immunoregulatory properties. Thymopentin interacts with T cells, reduces endocrine and behavioral responses to experimental stress. It is also found to increase the number of cells undergoing apoptosis in irradiated cells and selectively bind to apoptotic ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
At TREOS we discovered that an individual’s HLA genotype is the main determinant of immune responses. This breakthrough led to the development of the PEPI Test (CE Marked) that predicts peptide-specific T cell responses of HLA genotyped individuals. Based on the PEPI Test we have been co-developing with each PolyPEPI™ product a Companion Diagnostic to predict likely responders and ...
Manufactured by:Terumo Blood and Cell Technologies, Inc. based inLakewood, COLORADO (USA)
Finia is an automated system that formulates and aliquots fluids, including cell suspensions, to prepare for cryopreservation. It consists of a device, a handheld barcode scanner, a monitor with a touch screen and functionally closed single-use disposable tubing ...
Manufactured by:Santa Cruz Biotechnology, Inc. based inDallas, TEXAS (USA)
Concanamycin A is a specific inhibitor of vacuolar type H+-ATPase activity (V-ATPase) and is capable of inducing ...
by:Carina Biotech based inMawson Lakes, AUSTRALIA
Carina Biotech's proprietary manufacturing process leads to a greater efficiency in CAR-T cell ...
by:Carina Biotech based inMawson Lakes, AUSTRALIA
Antigen-binding domain, Optimised linker domain, CD8-derived transmembrane domain, 4-1BB co-stimulatory domain, CD3 zeta stimulatory domain, Engineered chemokine ...
Manufactured by:Ardigen based inKraków, POLAND
Accelerate discovery and improve safety of TCR therapies using Artificial Intelligence. Following the unique opportunity for curing patients provided by the development of cell therapies (e.g. TCR discovery), Ardigen has set on the path to advance the field with its Artificial Intelligence platform. Many challenges stand in the way of successful therapy discovery and development. Let us know how ...
Manufactured by:CytomX Therapeutics, Inc. based inSouth San Francisco, CALIFORNIA (USA)
CytomX and Amgen are developing CX-904, a T-cell engaging bispecific Probody candidate against Epidermal Growth Factor Receptor (EGFR) and CD3. The drug candidate is advancing towards IND-enabling studies. CytomX is responsible for the IND filing, targeted for late 2021, and for early clinical development with Amgen leading later stage development and ...
Manufactured by:Echelon Biosciences, Inc (EBI) based inSalt Lake City, UTAH (USA)
c ...
Manufactured by:TC BioPharm based inHolytown, UNITED KINGDOM
TCB007 is an unmodified allogeneic gamma delta T cell product, being used for the treatment of COVID-19. This product is at the CTA application stage and is expected to enter phase 1 trials in summer 2020. ...
Manufactured by:InteGen LLC based inOrlando, FLORIDA (USA)
Multiplex ALL-1 probe is a multicolored chromosome mix which consists of six chromosomes labeled with a predominant color scheme. Telomeres and pericentromeric regions on each chromosome are labeled with spectrally distinct fluorochrome. The mix is viewed three chromosomes at a time using dual filters. This design detects all numerical and structural abnormalities related to B- and T-cell Acute ...
Manufactured by:GeminiBio based inWest Sacramento, CALIFORNIA (USA)
GemCell Plus Xeno-Free Human Serum AB enables advanced therapy researchers and developers to streamline their workflow, allowing them to bring their end products to market quickly by providing human serum that is scalable, free of bovine components, uses therapeutic-grade human thrombin, and is rigorously ...
Manufactured by:IN8Bio Inc. based inNew York, NEW YORK (USA)
INB-400, our DeltEx Allo DRI, is a preclinical product candidate expanding the application of DRI gamma-delta T cells into other solid tumor types through the development of allogeneic or “off-the-shelf” DeltEx DRI therapy. We aim to take the clinical results from the ongoing INB-200 and INB-100 clinical trials to provide the safety data to support an IND submission for INB-400. The ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
An immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus (HBV). It is designed to drive CD4+ and CD8+ T-cell responses against all HBV genotypes in patients of diverse genetic backgrounds. Normally, the HBV virus is eliminated through T cell dependent mechanisms but stimulating these responses in chronically infected HBV patients has been ...
Manufactured by:Immudex ApS based inVirum, DENMARK
dCODE Dextramer technology enables the analysis of antigen-specific T cells by NGS or single-cell multi-omics. dCODE Dextramer adds a unique DNA barcode to the MHC Dextramer® reagent to detect antigen-specific T cells by NGS or single-cell multi-omics. High-avidity binding to T-cell receptors thanks to multiple MHC-peptide complexes. High-throughput screening with a unique barcode for each ...
Manufactured by:Lipotek based inActon, AUSTRALIA
Lipovax-Fg115 is an adjuvanted delivery vehicle for recombinant antigens. The platform exploits the commonly used his-tag to attach multiple copies of one or more type of antigens to the surface Lipovax-Fg115 particles. Our proprietary Fg115 molecules are also attached to the liposomes to stimulate the TLR5 receptor. The platform improves vaccine internalisation by dendritic cells and results in ...